PTPRC and neoplasm: Three fluorescently labeled antibodies targeting immune cells (CD45), epithelial cells (PanCK), tumor cells <i>(H3 K27M)</i> and a nucleic acid stain (SYTO-13) were used to establish regions of interest (ROI) for genomic and proteomic analysis.